Sort
16,300 grants matching “fatty liver disease”
DETECTION AND MODELS OF TOXICANT EXPOSURE
$715,297Robert H Tukey · University Of California, San Diego · P42 · FY2019 · ES
Administrative Core
$715,297Robert H Tukey · University Of California, San Diego · P42 · FY2019 · ES
Regulation of NF-Kappa B
$715,263Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2011 · AI
Epidemiologic studies of maternal and early life metabolic risk
$715,239Madhumita Sinha · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
$715,140Ryan Eugene Temel · Wake Forest University Health Sciences · R01 · FY2013 · HL
Core--Imaging
$715,015Melvin E Clouse · Beth Israel Deaconess Medical Center · P50 · FY2007 · HL
Fructose: Substrate, Stimulus, or Both?
$714,999Jean-Marc Schwarz · Touro University Of California · R01 · FY2020 · DK
Fructose: Substrate, Stimulus, or Both?
$714,999Jean-Marc Schwarz · Touro University Of California · R01 · FY2023 · DK
Fructose: Substrate, Stimulus, or Both?
$714,999Jean-Marc Schwarz · Touro University Of California · R01 · FY2019 · DK
Fructose: Substrate, Stimulus, or Both?
$714,999Jean-Marc Schwarz · Touro University Of California · R01 · FY2022 · DK
Regulation of NF-Kappa B
$714,981Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2012 · AI
Regulation of NF-Kappa B
$714,981Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2014 · AI
Targeting host lipid metabolism to limit tissue damage in necrotizing fasciitis
$714,614Steven J Bensinger · University Of California Los Angeles · R01 · FY2024 · AI
Targeting host lipid metabolism to limit tissue damage in necrotizing fasciitis
$714,614Steven J Bensinger · University Of California Los Angeles · R01 · FY2023 · AI
A New Translational Rat Model for Evaluating Anti-Aging Interventions
$714,165Arlan G. Richardson · University Of Oklahoma Hlth Sciences Ctr · R33 · FY2025 · AG
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
$713,949Ryan Eugene Temel · University Of Kentucky · R01 · FY2016 · HL
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD
$713,773Claude B Sirlin · University Of California, San Diego · R01 · FY2015 · DK
Molecular Magnetic Resonance Imaging of Inflammation
$713,467Eric Michael Gale · Massachusetts General Hospital · R01 · FY2025 · DK
Lipoprotein (a) Modification of the Impact of HIV Infection on Atherosclerotic Cardiovascular Disease
$713,464Thorsten M Leucker · Johns Hopkins University · R01 · FY2025 · HL
Animal Models for Studying the Genetics of Hypertension
$713,459Oliver Smithies · Univ Of North Carolina Chapel Hill · R01 · FY2010 · HL
Association between pre-diagnosis hepatic fat infiltration and risk of liver metastasis and mortality in a large cohort of stage I-III colorectal cancer survivors
$713,116Edward Giovannucci · Harvard School Of Public Health · R01 · FY2022 · CA
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
$712,481Gavin E Arteel · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Project 1 - Determining the contributions of the gut microbiota to the physiologi
$712,104Jeffrey Ivan Gordon · Washington University · P01 · FY2018 · DK
Pleiotropic Role of PAI-1 in Cardiovascular Aging
$712,074Douglas Eugene Vaughan · Northwestern University At Chicago · R01 · FY2023 · HL
Role of IGF-1 and insulin receptors beta-cell survival
$711,982Rohit N. Kulkarni · Joslin Diabetes Center · R01 · FY2025 · DK